Blockbuster Drug stories:
UPDATE 1-US FDA staff question Pfizer lung drug data
Nov 17th, 2009 - Reuters
* Boehringer, Pfizer seek new claim for Spiriva * FDA notes statistical issues, safety concerns * Boehringer says drug not linked with more deaths WASHINGTON, Nov 17 (Reuters) - U.S...
Abbott to buy Solvay unit for 4.5 bln euros-source
Sep 27th, 2009 - Reuters
NEW YORK, Sept 27 (Reuters) - U.S. drugmaker Abbott Laboratories (ABT.N) is expected to buy Solvay SA's(SOLB.BR) pharmaceuticals unit for 4.5 billion euros ($6.6billion)...
Dendreon Drug Clears Difficult Hurdle, But Others Remain
Apr 29th, 2009 - Wall Street Journal
NEW YORK (Dow Jones)--Dendreon Corp. (DNDN) has cleared a significant hurdle in bringing its controversial prostate cancer treatment Provenge to market, but obstacles remain before the drug gets launched. Provenge could be a blockbuster drug...



